Minghui Qin1, Lai Wang1, Fuqiang Li1, Mingjie Yang1, Lei Song1, Fang Tian1, Ada Yukht1, Prediman K Shah1, Marc E Rothenberg2, Behrooz G Sharifi3. 1. Oppenheimer Atherosclerosis Research Center, Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA, USA. 2. Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 3. Oppenheimer Atherosclerosis Research Center, Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA, USA. Electronic address: Sharifi@cshs.org.
Abstract
BACKGROUND AND AIMS: Inflammation, particularly innate immunity, plays an important role in cardiovascular diseases. The aim of this study was to investigate whether atherogenic determinants such as oxidized LDL modulate the phenotype of eosinophils. METHODS: Cultured eosinophils were treated with oxidized LDL and the expression of selective inflammatory and anti-inflammatory cytokines was determined. In addition, the eosinophil receptor and signaling that mediate these events were identified. RESULTS: Treatment of cultured eosinophils with oxidized LDL (Ox-LDL) specifically induced the expression of IFNα and IFNβ without affecting expression of other proinflammatory cytokines, such as TNFα, IL-1β, and IL-6. In macrophages, Ox-LDL downregulated expression of both IFNα and IFNβ, suggesting that the effect of Ox-LDL on the expression of type I interferons is specific to eosinophils. Furthermore, we noted that eosinophils constitutively expressed IL-4 and IL-13, and Ox-LDL markedly downregulated their expression. Analysis of Ox-LDL signaling revealed that eosinophils constitutively expressed SRB2, CD36, and CD68 scavenger receptors, and Ox-LDL markedly induced the expression of CD36. Further analysis of CD36 signaling by siRNA and neutralizing antibodies showed that the induction of type I IFN by Ox-LDL is mediated by CD36 signaling whereas downregulation of IL-4 is independent of CD36 activation. We further showed that peritoneal macrophages treated with condition medium collected from Ox-LDL treated eosinophils markedly induced the expression of M1 markers such as iNOS, IL6, SOSC3 and TNFα whereas the condition medium from non-treated eosinophils significantly induced expression of M2 markers like ARG1 and CCL24. CONCLUSIONS: Our data suggest that an atherogenic condition could activate eosinophils and modulate the phenotype of macrophages (from M2 to M1 phenotype), in part, through the CD36 receptor signaling.
BACKGROUND AND AIMS: Inflammation, particularly innate immunity, plays an important role in cardiovascular diseases. The aim of this study was to investigate whether atherogenic determinants such as oxidized LDL modulate the phenotype of eosinophils. METHODS: Cultured eosinophils were treated with oxidized LDL and the expression of selective inflammatory and anti-inflammatory cytokines was determined. In addition, the eosinophil receptor and signaling that mediate these events were identified. RESULTS: Treatment of cultured eosinophils with oxidized LDL (Ox-LDL) specifically induced the expression of IFNα and IFNβ without affecting expression of other proinflammatory cytokines, such as TNFα, IL-1β, and IL-6. In macrophages, Ox-LDL downregulated expression of both IFNα and IFNβ, suggesting that the effect of Ox-LDL on the expression of type I interferons is specific to eosinophils. Furthermore, we noted that eosinophils constitutively expressed IL-4 and IL-13, and Ox-LDL markedly downregulated their expression. Analysis of Ox-LDL signaling revealed that eosinophils constitutively expressed SRB2, CD36, and CD68 scavenger receptors, and Ox-LDL markedly induced the expression of CD36. Further analysis of CD36 signaling by siRNA and neutralizing antibodies showed that the induction of type I IFN by Ox-LDL is mediated by CD36 signaling whereas downregulation of IL-4 is independent of CD36 activation. We further showed that peritoneal macrophages treated with condition medium collected from Ox-LDL treated eosinophils markedly induced the expression of M1 markers such as iNOS, IL6, SOSC3 and TNFα whereas the condition medium from non-treated eosinophils significantly induced expression of M2 markers like ARG1 and CCL24. CONCLUSIONS: Our data suggest that an atherogenic condition could activate eosinophils and modulate the phenotype of macrophages (from M2 to M1 phenotype), in part, through the CD36 receptor signaling.
Authors: Pieter Goossens; Marion J J Gijbels; Alma Zernecke; Wouter Eijgelaar; Monique N Vergouwe; Ingeborg van der Made; Joris Vanderlocht; Linda Beckers; Wim A Buurman; Mat J A P Daemen; Ulrich Kalinke; Christian Weber; Esther Lutgens; Menno P J de Winther Journal: Cell Metab Date: 2010-08-04 Impact factor: 27.287
Authors: Daniel Piehler; Werner Stenzel; Andreas Grahnert; Josephin Held; Lydia Richter; Gabriele Köhler; Tina Richter; Maria Eschke; Gottfried Alber; Uwe Müller Journal: Am J Pathol Date: 2011-05-31 Impact factor: 4.307
Authors: E Economou; D Tousoulis; A Katinioti; C Stefanadis; A Trikas; C Pitsavos; C Tentolouris; M G Toutouza; P Toutouzas Journal: Int J Cardiol Date: 2001-08 Impact factor: 4.164
Authors: Lai Wang; Mingjie Yang; Ana Arias; Lei Song; Fuqiang Li; Fang Tian; Minghui Qin; Ada Yukht; Ian K Williamson; Prediman K Shah; Behrooz G Sharifi Journal: PLoS One Date: 2015-06-03 Impact factor: 3.240
Authors: Iqbal S Toor; Dominik Rückerl; Iris Mair; Rob Ainsworth; Marco Meloni; Ana-Mishel Spiroski; Cecile Benezech; Jennifer M Felton; Adrian Thomson; Andrea Caporali; Thomas Keeble; Kare H Tang; Adriano G Rossi; David E Newby; Judith E Allen; Gillian A Gray Journal: JACC Basic Transl Sci Date: 2020-07-08